These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 17922993

  • 21. [Relationships between liver function test, serum HBeAg or HBV DNA level and liver pathological changes in patients with chronic hepatitis B].
    Xu QH, Shu X, Chen LB, Huang HH, Zhang K, Li G.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):422-4. PubMed ID: 19544633
    [Abstract] [Full Text] [Related]

  • 22. Quantification of intrahepatic total hepatitis B virus DNA in chronic hepatitis B patients and its relationship with liver histology.
    Bayram A, Erkilic S, Ozkur A, Bayram M, Sari I.
    J Clin Pathol; 2008 Mar; 61(3):338-42. PubMed ID: 17693576
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B.
    Nikolaidis N, Vassiliadis T, Giouleme O, Tziomalos K, Grammatikos N, Patsiaoura K, Orfanou-Koumerkeridou E, Balaska A, Eugenidis N.
    Clin Transplant; 2005 Jun; 19(3):321-6. PubMed ID: 15877792
    [Abstract] [Full Text] [Related]

  • 26. [The clinical significance of quantitation of HBV DNA in serum-comparison of the branched-DNA assay with the second-generation digene hybrid capture assay and long-term observation].
    Jun EJ, Han JY, Choi H, Chang UI, Lee TK, Kim YH, Kim JI, Park SH, Kim JK, Chung KW, Sun HS.
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):157-66. PubMed ID: 12499801
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 29. Short-term lamivudine therapy in HBeAg-negative chronic active hepatitis B in Taiwan.
    Chien RN, Liaw YF.
    Antivir Ther; 2006 Jan; 11(7):947-52. PubMed ID: 17302259
    [Abstract] [Full Text] [Related]

  • 30. Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial.
    Chan HL, Wang H, Niu J, Chim AM, Sung JJ.
    Antivir Ther; 2007 Jan; 12(3):345-53. PubMed ID: 17591024
    [Abstract] [Full Text] [Related]

  • 31. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL, Luo KX, Feng XR, Fu QX, Hou JL.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 10; 87(26):1840-3. PubMed ID: 17922996
    [Abstract] [Full Text] [Related]

  • 32. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS.
    Liver Int; 2007 Aug 10; 27(6):806-15. PubMed ID: 17617124
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Predictive factors of hepatitis B virus DNA negative conversion among patients with chronic hepatitis B during lamivudine therapy].
    Chen JL, Wang L, Yan J, Zhang L, Yu H, Fan XL.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep 10; 21(3):273-5. PubMed ID: 17971944
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H.
    J Med Virol; 2007 Sep 10; 79(9):1286-92. PubMed ID: 17607775
    [Abstract] [Full Text] [Related]

  • 37. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B, Mukhopadhya A, Kurian G.
    J Gastroenterol Hepatol; 2008 Nov 10; 23(11):1734-8. PubMed ID: 18713304
    [Abstract] [Full Text] [Related]

  • 38. Natural history of hepatitis B.
    Marcellin P, Castelnau C, Martinot-Peignoux M, Boyer N.
    Minerva Gastroenterol Dietol; 2005 Mar 10; 51(1):63-75. PubMed ID: 15756147
    [Abstract] [Full Text] [Related]

  • 39. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.
    Sun HC, Zhang W, Qin LX, Zhang BH, Ye QH, Wang L, Ren N, Zhuang PY, Zhu XD, Fan J, Tang ZY.
    J Hepatol; 2007 Nov 10; 47(5):684-90. PubMed ID: 17854945
    [Abstract] [Full Text] [Related]

  • 40. [The clinic features and the short-term efficacy of entecavir treatment of the HBeAG negative acute-on-chronic hepatitis B liver failure].
    Shu X, Xu QH, Chen N, Zhang K, Li G.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec 10; 22(6):481-3. PubMed ID: 19544652
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.